Superinfection with hepatitis C virus in patients with symptomatic chronic hepatitis B. Scand J Infect Dis 1991;23:421-424. 7. Gaeta GB, Stornaiuolo G, Precone DF, Lobello S, Chiaramonte M, Stroffolini T, Colucci G, et al. Epidemiological and clinical burden of chronic hepatitis B virus/hepat[r]
18. Farci P, et al. Hepatitis C virus-associated fulminant hepatic failure. N Engl J Med, 1996. 335(9): 631-4. 19. Vogt M, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Eng[r]
the exact prevalence of which is unknown. Int. J. Med. Sci. 2006, 3 37Chronic hepatitis C In patients with clinical or biological signs of chronic liver disease, chronic hepatitis C is certain when both anti-HCV antibodies and HCV RNA (sought for with a sensitive technique, detecting 5[r]
the HIV-1-infected individuals because no Thai nor-mative data were available to analyze the results. All individuals had minimal/distant or no exposure to illicit drug use with negative urine toxicology screens on two occasions within 30 days prior to enrollment. Subjects were all seronegative for[r]
20. Hwang SJ, Luo JC, Chu CW, et al. Hepatic steatosis in chronic hepatitis C virus infection: Prevalence and clinical correlation. J Gastroenterol Hepatol 2001;16:190-5. 21. Lonardo A, Adinolfi LE, Loria P, et al. Steatopsis and hepatitis C virus: Mechanisms and significance for hepat[r]
(PR) weight based dosing (WBD). In: 40th Annual meeting of the European Association for the Study of Liver Disease; April 13-17, 2005; Paris, France. Int. J. Med. Sci. 2006, 3 7812. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, Detre K, Hoofnagle J. Predictors of patient and gr[r]
with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia. J Hepatol. 2006;44(1):97-103. 10. Drusano GL, Preston SL. A 48-week duration of therapy with pegylated interferon alpha 2b plus ribavirin may be too short to m[r]
HCV develop chronic infection or have the same degree of liver disease progression. Several factors have been identified to influence the rate of progression to cirrhosis in the HCV chronically infected population. Unfavourable factors include male age, age >40 years at infection, significant[r]
association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-96. 10. Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, Moya A, Orbis F, Mir J, Berenguer J. Contribution of donor age to the recent decrease in pa[r]
4. Serfaty L, Aumaitre H, Chazouilleres O, Bonnand AM, Rosmorduc O, Poupon RE, et al. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology 1998;27:1435-1440. 5. Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K, Kakumu S, Iijima A, Urushihara A, Ki[r]
hepatitis C virus to CD81. Science 1998; 282: 938-41. 25. Agnello V, Abel G, Elfahal M, Knight GB and Zhang QX. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A 1999; 96: 12766-71. 26. Scarselli E, Ansuini H, Ce[r]
is the second most common cause of death from cancer [1]. Helicobacter pylori (H. pylori) strains carrying the cytotoxin-associated gene A (cagA) gene are strongly associated with increased risk of gastric adenocarcinoma [2]. However, only some of those infected developed H. pylori-related disease s[r]
. The PCR was con-ducted with initial denaturation at 95°C for 10 minutes, 30 cycles of denaturation at 95°C for 1 minute, an-nealing at 60°C for 1 minute, and extension at 72°C for 1 minute, and a final extension at 72°C for 5 minutes. The primers were F1: 5’-AGC[r]
malformations. However, the infrequent maternal use of loratadine and the prevalence of hypospadias have a major impact on sample size requirements for providing the definitive assurances of the safety of loratadine to the unborn child [29]. Thus, to rule out a doubling of the risk of hypospadias wo[r]
the RM group (χ2=1.60, p=0.21). The genotypes of TNF-A T-1031C had no associations with the eradication rate. But among the RM group, the odd ratio (OR) of the TNF-A CT for the eradication rate relative to TT was marginally reduced (OR=0.05, 95% confidence interval, 0.002-1.19). Conclusions:[r]
methods outlined in previous reports [18]. The recombinant clones were identified by using a PCR. The pAdeasy-1 contains the human adenovirus type 5 genome with E1 and E3 deletions. The recombinant adenoviral plasmids, pADrBMP4 and pADrBMP6, were cleaved with PacI to expose their inverted terminal r[r]
1. INTRODUCTION Hb J-Meerut results from a C ->A mutation (GCG->GAG) at codon 120 of the α1 or α2 globin gene, changing the alanine to glutamic acid at residue 120 of the α chain [1,2,3]. This variant was first reported in two sisters from Meerut, Utlar Pradesh, India [1] and in[r]